1
Return

Innovative immune checkpoint modulators: monoclonal antibodies, small molecules, non-coding RNAs, and nanoparticles in cancer immunotherapy

delete2026-06-11
delete0
PRE
AI
S
Sevda Jafari
H
Habib Zarredar
A
Alireza Ostadrahimi
A
Ailar Nakhlband
V
Vahid Hosseini
S
Soheila Montazersaheb *
N
Naimeh Mesri Alamdari *
DOI：10.1016/j.cyto.2026.157177delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
• mAbs, small molecules, and ncRNAs advance the checkpoint regulation. • Nanoparticles enhance targeted delivery and therapeutic precision. • Novel checkpoint modulators may overcome resistance to immunotherapy. • Combined approaches support personalized cancer treatment.

Journal

Cytokine cover
Cytokine
IF:
3.7
Papers:
9.7K
Citations:
1.4W

Organization

T
Tabriz University of Medical Sciences
Scholars:
1.3K
Papers: 576
Citations: 10.0K
I
islamic azad university
Scholars:
4.0K
Papers: 2.0K
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers